Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Scientists find antidepressant, bone loss link

26.06.2007
Physician says published findings 'raise some concern about people taking SSRIs'

Two new studies suggest older men and women taking selective serotonin reuptake inhibitors, a class of antidepressants that includes Prozac, Paxil and Zoloft, are prone to increased bone loss.

The jointly released studies by scientists at Oregon Health & Science University, and in San Francisco, Minneapolis, San Diego and Pittsburgh, found that elderly men taking the so-called SSRIs had lower bone mineral density, and that elderly women taking the antidepressants had a higher rate of yearly bone loss.

The studies appear in today's issue of Archives of Internal Medicine, a publication of the Journal of the American Medical Association.

The studies "raise some concern about people taking SSRIs and whether they may need additional screening or extra protection for their bones," said Elizabeth Haney, M.D., assistant professor of medicine (general internal medicine and geriatrics) in the OHSU School of Medicine who led the men's study and co-authored the women's study.

But Haney cautioned the studies' results don't confirm a "cause-and-effect relationship" between SSRIs and bone loss. "Both are observational studies, so without a prospective study of this issue, we're unable to make a determination of direct causality," she said.

The studies also found that use of another popular class of antidepressant medications, known as tricyclic antidepressants or TCAs, were not associated with increased bone loss in men and women. TCAs include such drugs as amitriptyline (Elavil), desipramine (Norpramin), doxepin (Sinequan), imipramine (Tofranil) and nortriptyline (Pamelor).

For the men's study, which measured total bone loss, researchers analyzed health data for 5,995 men ages 65 and older who were recruited from six regions of the United States between March 2000 and April 2002. They found that bone mineral density among SSRI users was 3.9 percent lower at the total hip and 5.9 percent lower at the lumbar spine compared with men not taking the antidepressants.

For the women's study, a longitudinal study measuring bone loss rate, researchers first examined 2,722 women ages 65 and older from four regions between 1986 and 1988, and again between 1997 and 1998. Bone mineral density in the total hip decreased .47 percent among participants who didn't use SSRIs, but .82 percent among people who did take the drugs.

Michael Bliziotes, M.D., OHSU associate professor of medicine (endocrinology, diabetes and clinical nutrition) who was senior author on the men's study and co-author on the women's study, said the research team was "surprised at the degree of difference we saw. I wasn't anticipating it would be that much."

That's because there are so many other factors that could affect bone density, the researchers said. For example, older men taking SSRIs have lower physical activity or greater intake of alcohol. And older women tend to be more depressed than men, and they lose bone density at a greater rate earlier in life due to menopause.

"One of the concerns we had was depression has its own effects on bones, so depressed people probably have lower bone density independent of their SSRI use," Bliziotes said. "Still we found that the bone density was lower in SSRI users even after controlling for as many confounding variables as we could."

Haney and Bliziotes both agree the results don't mean people taking antidepressants, even SSRIs, should stop.

"Depression is a serious condition and it's important not to stop antidepressants abruptly or without talking to your physician," Haney said. "However, it may be worth paying special attention to the things we know can prevent osteoporosis, such as exercise, taking adequate calcium and vitamin D, and it might be worth consideration of screening for low bone density."

Bliziotes added, "We don't want to leave anyone with the impression that if they're on an SSRI for a valid reason, they should go off it. They have benefits, they've been demonstrated, and people have been put on them for valid reasons, so we don't want to do anything that would jeopardize that."

Haney said future studies will continue to track bone density changes over time to help researchers determine the effects of SSRI use on markers of bone cell turnover.

Jonathan Modie | EurekAlert!
Further information:
http://www.ohsu.edu

More articles from Studies and Analyses:

nachricht Antarctic Ice Sheet mass loss has increased
14.06.2018 | Technische Universität Dresden

nachricht WAKE-UP provides new treatment option for stroke patients | International study led by UKE
17.05.2018 | Universitätsklinikum Hamburg-Eppendorf

All articles from Studies and Analyses >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Temperature-controlled fiber-optic light source with liquid core

In a recent publication in the renowned journal Optica, scientists of Leibniz-Institute of Photonic Technology (Leibniz IPHT) in Jena showed that they can accurately control the optical properties of liquid-core fiber lasers and therefore their spectral band width by temperature and pressure tuning.

Already last year, the researchers provided experimental proof of a new dynamic of hybrid solitons– temporally and spectrally stationary light waves resulting...

Im Focus: Overdosing on Calcium

Nano crystals impact stem cell fate during bone formation

Scientists from the University of Freiburg and the University of Basel identified a master regulator for bone regeneration. Prasad Shastri, Professor of...

Im Focus: AchemAsia 2019 will take place in Shanghai

Moving into its fourth decade, AchemAsia is setting out for new horizons: The International Expo and Innovation Forum for Sustainable Chemical Production will take place from 21-23 May 2019 in Shanghai, China. With an updated event profile, the eleventh edition focusses on topics that are especially relevant for the Chinese process industry, putting a strong emphasis on sustainability and innovation.

Founded in 1989 as a spin-off of ACHEMA to cater to the needs of China’s then developing industry, AchemAsia has since grown into a platform where the latest...

Im Focus: First real-time test of Li-Fi utilization for the industrial Internet of Things

The BMBF-funded OWICELLS project was successfully completed with a final presentation at the BMW plant in Munich. The presentation demonstrated a Li-Fi communication with a mobile robot, while the robot carried out usual production processes (welding, moving and testing parts) in a 5x5m² production cell. The robust, optical wireless transmission is based on spatial diversity; in other words, data is sent and received simultaneously by several LEDs and several photodiodes. The system can transmit data at more than 100 Mbit/s and five milliseconds latency.

Modern production technologies in the automobile industry must become more flexible in order to fulfil individual customer requirements.

Im Focus: Sharp images with flexible fibers

An international team of scientists has discovered a new way to transfer image information through multimodal fibers with almost no distortion - even if the fiber is bent. The results of the study, to which scientist from the Leibniz-Institute of Photonic Technology Jena (Leibniz IPHT) contributed, were published on 6thJune in the highly-cited journal Physical Review Letters.

Endoscopes allow doctors to see into a patient’s body like through a keyhole. Typically, the images are transmitted via a bundle of several hundreds of optical...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Munich conference on asteroid detection, tracking and defense

13.06.2018 | Event News

2nd International Baltic Earth Conference in Denmark: “The Baltic Sea region in Transition”

08.06.2018 | Event News

ISEKI_Food 2018: Conference with Holistic View of Food Production

05.06.2018 | Event News

 
Latest News

Creating a new composite fuel for new-generation fast reactors

20.06.2018 | Materials Sciences

Game-changing finding pushes 3D-printing to the molecular limit

20.06.2018 | Materials Sciences

Could this material enable autonomous vehicles to come to market sooner?

20.06.2018 | Materials Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>